2008
Does Surgeon Case Volume Influence Nonfatal Adverse Outcomes after Rectal Cancer Resection?
Billingsley K, Morris A, Green P, Dominitz J, Matthews B, Dobie S, Barlow W, Baldwin L. Does Surgeon Case Volume Influence Nonfatal Adverse Outcomes after Rectal Cancer Resection? Journal Of The American College Of Surgeons 2008, 206: 1167-1177. PMID: 18501815, PMCID: PMC3103396, DOI: 10.1016/j.jamcollsurg.2007.12.042.Peer-Reviewed Original ResearchConceptsSurgeon volumeSurgeon ageProcedural interventionEnd Results (SEER) cancer registry programNonfatal adverse outcomesRectal cancer careMajor postoperative complicationsRectal cancer resectionEnd Results (SEER) dataCancer Registry ProgrammeRectal cancer patientsRectal cancer surgeryRetrospective cohort designHigh-volume surgeonsRectal cancer operationsPostoperative complicationsColorectal surgeryHospital volumeSurgical complicationsCancer resectionPrimary outcomeRectal cancerSevere complicationsCancer surgeryCancer operations
2006
Completion of Therapy by Medicare Patients With Stage III Colon Cancer
Dobie S, Baldwin L, Dominitz J, Matthews B, Billingsley K, Barlow W. Completion of Therapy by Medicare Patients With Stage III Colon Cancer. Journal Of The National Cancer Institute 2006, 98: 610-619. PMID: 16670386, PMCID: PMC3124351, DOI: 10.1093/jnci/djj159.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColonic NeoplasmsFemaleFrail ElderlyHumansLogistic ModelsMaleMedicareNeoplasm StagingPatient CompliancePredictive Value of TestsReproducibility of ResultsRisk FactorsSEER ProgramSocial SupportUnited StatesConceptsStage III colon cancerCompletion of therapyAdjuvant chemotherapyAdjuvant therapyChemotherapy completionPhysician characteristicsMedicare claimsColon cancerStage III colon cancer patientsEnd Results program dataMultivariable logistic regression modelingAdjuvant chemotherapy completionChemotherapy completion rateIncomplete adjuvant chemotherapySEER program dataColon cancer resectionCancer-related mortalityPredictors of initiationColon cancer patientsLogistic regression modelingProgram dataPatient characteristicsCancer resectionTreatment complicationsCancer mortality
2005
Explaining Black–White Differences in Receipt of Recommended Colon Cancer Treatment
Baldwin L, Dobie S, Billingsley K, Cai Y, Wright G, Dominitz J, Barlow W, Warren J, Taplin S. Explaining Black–White Differences in Receipt of Recommended Colon Cancer Treatment. Journal Of The National Cancer Institute 2005, 97: 1211-1220. PMID: 16106026, PMCID: PMC3138542, DOI: 10.1093/jnci/dji241.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBlack or African AmericanChemotherapy, AdjuvantCohort StudiesColonic NeoplasmsComorbidityFemaleHealth Services AccessibilityHumansLength of StayMaleMedicareOdds RatioPractice Patterns, Physicians'Retrospective StudiesRisk FactorsSEER ProgramSeverity of Illness IndexSocial SupportSocioeconomic FactorsUnited StatesWhite PeopleConceptsHealth system factorsBlack-White disparitiesChemotherapy receiptWhite patientsMedical oncologistsBlack patientsCancer treatmentRetrospective cohort studyBlack-white differencesColon cancer resectionAmerican Medical Association MasterfileEnd Results ProgramColorectal cancer treatmentColon cancer careColon cancer patientsLogistic regression analysisSystem factorsRegression analysisNeighborhood socioeconomic statusColon cancer treatmentAdjuvant chemotherapyChemotherapy useCohort studyCancer resectionIllness severity